Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases

Hiromi Suzuki, Atsushi Hatamochi, Michio Hasikabe, Soji Yamazaki, Motohiko Tamura, Hiromi Ishihama, Shinichiro Miyoshi

Research output: Contribution to journalArticle

Abstract

Gefitinib (Iressa®) is a new anticancer agent against lung cancer that acts by inhibiting signal transduction of the growth factor receptor. We describe six patients receiving gefitinib (250mg/day) who developed an acne-like eruption consisting of follicular papules and pustules on their faces, chests and/or backs. A histopathological examination of one patient revealed an inflammatory cell infiltration around the hair follicles.

Original languageEnglish
Pages (from-to)599-601
Number of pages3
JournalNishinihon Journal of Dermatology
Volume66
Issue number6
DOIs
Publication statusPublished - Dec 1 2004

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases'. Together they form a unique fingerprint.

  • Cite this

    Suzuki, H., Hatamochi, A., Hasikabe, M., Yamazaki, S., Tamura, M., Ishihama, H., & Miyoshi, S. (2004). Acneiform follicular eruption in patients treated with Gefitinib: Report of six cases. Nishinihon Journal of Dermatology, 66(6), 599-601. https://doi.org/10.2336/nishinihonhifu.66.599